1997
DOI: 10.1002/hep.510260329
|View full text |Cite
|
Sign up to set email alerts
|

Transmission of a homogenous hepatitis B virus population of A1896-containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis B e antigen antibodies in an adult

Abstract: Although the molecular biology is reasonably straightforThe pre-core variant, A 1896 , which switches off hepatitis B ward, associations with clinical outcome are less firm. A 1896 e antigen (HBeAg) production, is common in hepatitis B e was first discovered in persons with hepatitis B e antigen antigen antibody (anti-HBe)-positive chronic hepatitis paantibody (anti-HBe)-positive severe chronic hepatitis, 1,2 but tients. It has been observed in occasional case reports of acute was subsequently found in those w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
5
0

Year Published

1999
1999
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 16 publications
2
5
0
Order By: Relevance
“…However, its role in HBsAg clearance still needs elucidation. This study demonstrates for the first time the association between the G1896A mutation and a shorter time to HBsAg clearance, extending the observation that it can occur very early after infection (or could indeed be transmitted, as previously suggested [ 33 ]). Although in chronic infection G1896A has been controversially suspected of being related to decompensated cirrhosis or cancer [ 34 , 35 ], in acute hepatitis it could be rather considered as a marker of a potent cytotoxic immune response (at genotype parity), generating more severe liver alterations [ 36 ] but most successful at clearing the infection.…”
Section: Discussionsupporting
confidence: 88%
“…However, its role in HBsAg clearance still needs elucidation. This study demonstrates for the first time the association between the G1896A mutation and a shorter time to HBsAg clearance, extending the observation that it can occur very early after infection (or could indeed be transmitted, as previously suggested [ 33 ]). Although in chronic infection G1896A has been controversially suspected of being related to decompensated cirrhosis or cancer [ 34 , 35 ], in acute hepatitis it could be rather considered as a marker of a potent cytotoxic immune response (at genotype parity), generating more severe liver alterations [ 36 ] but most successful at clearing the infection.…”
Section: Discussionsupporting
confidence: 88%
“…The co-existence therefore of HBeAg- with non-HBeAg-producing variants may be due to the preexistence of the wild-type virus or due to degraded core, released as a result of the extensive liver tissue damage. Anti-HBe has been detected following transmission of the G1896A variant, even though in this case report, HBeAg was not detectable during the acute phase (Mphahlele et al , 1997 ). HBeAg epitopes can therefore be presented to the immune system by degraded core protein, and lead to the production of anti-HBe, in the absence of the authentic protein.…”
Section: Discussionmentioning
confidence: 72%
“…It is known that HBeAg is not required for HBV replication and its exact function is unclear, but may play a role in chronic HBV infection 17, 18 . The emergence of HBeAg-negative variants correlates with an exacerbation of liver injury in some patients 20, 21 . HBeAg modulates host immune response during CHB progression 22 , suppresses TLR-induced IFN-β and ISG production in liver cells 23 , and inhibits IL-18 signaling and IFN-γ expression in NK and hepatoma cells 36 .…”
Section: Discussionmentioning
confidence: 99%
“…The emergence of HBeAg-negative variants correlates with an exacerbation of liver injury and even with viral clearance in some patients 20, 21 . HBeAg is responsible for modulation of host immune response during CHB progression, inhibits TLR-2 expression, and abrogates the antiviral activity of TLR signaling via suppressing IFN-β and ISG production 22–25 .…”
Section: Introductionmentioning
confidence: 99%